Early gut barrier dysfunction in patients with severe acute pancreatitis: Attenuated by continuous blood purification treatment

International Journal of Artificial Organs

Volumn 33, Issue 10, 2010, Pages 706-715

  Zhang, JianBin ^a   Yuan, Chen ^a   Hua, Gan ^b   Tong, RuYan ^a   Luo, XiangFeng ^a   Ying, Zhou ^a  

^a NANCHANG UNIVERSITY   (China)

^b CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Actin; Continuous veno venous hemofiltration; Epithelial permeability; iNOS; Intestinal mucosal dysfunction; Pancreatitis

Indexed keywords

CELL MEMBRANES; PATIENT TREATMENT; PROTEINS; PURIFICATION; BLOOD;

ACTIN; BLOOD PURIFICATION; CONTINUOUS VENO-VENOI HEMOFILTRATION; EPITHELIAL PERMEABILITY; GUT BARRIER; HEMOFILTRATION; INOS; INTESTINAL MUCOSAL DYSFUNCTION; PANCREATITIS; SEVERE ACUTE PANCREATITIS;

BLOOD; PROTEINS;

AMINE OXIDASE (COPPER CONTAINING); ENDOTOXIN; F ACTIN; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE;

ACUTE PANCREATITIS; ADULT; AGED; ARTICLE; BLOOD FILTRATION; BLOOD SAMPLING; CLINICAL TRIAL; CONTINUOUS BLOOD PURIFICATION; CONTROLLED CLINICAL TRIAL; DISEASE SEVERITY; DOWN REGULATION; EARLY GUT MUCOSA DYSFUNCTION; ELECTRIC RESISTANCE; ENZYME BLOOD LEVEL; FEMALE; HUMAN; INTESTINE EPITHELIUM; INTESTINE FUNCTION DISORDER; INTESTINE MUCOSA PERMEABILITY; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; UPREGULATION;

EID: 78649232527     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139881003301003     Document Type: Article

References (24)

1. Carnovale A, Rabitti PG, Manes G, et al. Mortality in acute pancreatitis: is it an early or a late event? JOP 2005; 6: 438-44.
2. Leaphart CL, Tepas JJ. The gut is a motor of organ system dysfunction. Surgery 2007; 141: 563-9.
3. Haiyan Liu MD, Weiqin Li MD, Xinying Wang MD, et al. Early Gut Mucosal Dysfunction in patients with Acute Pancreatitis. Pancreas 2008; 2: 192-6.
4. Ammori BJ. Gut barrier dysfunction in patients with acute pancreatitis. J Hepatobiliary Pancreat Surg 2002; 9: 411-2.
5. Haenisch B, von Kügelgen I, Bönisch H, et al. Regulatory mechanisms underlying agmatine homeostasis in humans. Am J Physiol Gastrointest Liver Physiol 2008; 295: G1104-10.
6. Liu H, Li W, Wang X, et al. Early Gut Mucosal Dysfunction in Patients With Acute Pancreatitis. Pancreas 2008; 36: 192-6.
7. Lin H, Gebhardt M, Bian S, et al. Enhancing effect of surfactants on fexofenadine. HCl transport across the human nasal epithelial cell monolayer. Int J Pharm 2007; 330: 23-31.
8. Wang H, Li WQ, Zhou W, et al. Clinical effects of continuous high volume hemofiltration on severe acute pancreatitis complicated with multiple organ dysfunction syndrome. World J Gastroenterol 2003; 9: 2096-9.
9. Mao EQ, Tang yQ, Zhang SD. Effects of time interval for hemofiltration on the prognosis of severe acute pancreatitis. World J Gastroenterol 2003; 9: 373-6.
10. Pupelis G, Plaudis H, Grigane A, et al. Continuous venovenous haemofiltration in the treatment of severe acute pancreatitis: 6-year experience. HBP 2007; 9: 295-301.
11. yekebas EF, Strate T, Zolmajd S, et al. Impact of different modalities of continuous venovenous hemofiltration on sepsis- induced alterations in experimental pancreatitis. Kidney Int 2002; 62: 1806-18.
12. Ammori BJ, Leeder PC, King RF, et al. Early increase in intestinal permeability in patients with severe acute pancreatitis: correlation with endotoxemia, organ failure, and mortality. J Gastrointest Surg 1999; 3: 252-62.
13. Hirotani O, Ikeda K, Kato R, et al. Protective Effects of Lactoferrin against intestinal Mucosal Damage Induced by Lipopolysaccharide in Human Intestinal Caco-2 Cells. yakugaku Zasshi 2008; 128:1363-8.
14. Banan A, Choudhary S, Zhang y, et al. Oxidant-induced intestinal barrier disruption and its prevention by growth factors in a human colonic cell line: role of the microtubule cytoskeleton. Free Radic Biol Med 2000; 28: 727-38.
15. Mayumi T, Ura H, Arata S, et al. Evidence-based clinical practice guidelines for acute pancreatitis:proposals. J Hepatobiliary Pancreat Surg 2002; 9: 413-22.
16. Emre F, yekebas MD, Claus F, et al. Attenuation of sepsisrelated immunoparalysis by continuous venovenous hemo- filtration in experimental porcine pancreatitis. Crit Care Med 2001; 29: 1423-30.
17. Anthony T, Blikslager AJ, et al. Restoration of Barrier function in injured intestinal mucosa. Physiol Rev 2007; 87: 545-64.
18. Bana A, Fields JZ, Zhang y, et al. iNOS upregulation mediates oxidant-induced disruption of F-actin and barrier of intestinal monolayers. Am J Physiol 2001; 280: G1234-46.
19. Chavez A, Menconi MJ, Hodin RA, et al. Cytokine-induced epithelial hyperpermeability: role of nitric oxide. Crit Care Med 1999; 27: 2246-51.
20. Gobert AP, Cheng y, Akhtar M, et al. Protective role of arginase in a mouse model of colitis. J Immunol 2004; 173: 2109-17.
21. Salzman AL, Eaves-Pyles T, Linn SC, et al. Bacterial induction of inducible nitric oxide synthase in cultured human intestinal epithelial cells. Gastroenterology 1998; 114: 93-102.
22. Chen ZH, Liu ZH, yu C, et al. Endothelial dysfunction in patients with severe acute pancreatitis: Improved by continous blood purification therapy. Int J Artif Organs 2007; 30: 393-400.
23. yu C, Liu ZH, Chen ZH, et al. Improvement of monocyte function and immune homeostasis by high volume continuous venovenous hemofiltration in patients with severe acute pancreatitis. Int J Artif Organs 2008; 31: 882-90.
24. Zhang JB, Du XG, Zhang H, et al. Breakdown of the gut barrier in patients with multiple organ dysfunction syndrome is attenuated by continuous blood purification: effects on tight junction structural proteins. Int J Artif Organs 2010; 33: 5-14.